Tel Aviv-based AI-enabled computational protein engineering platform Scala Biodesign announced its launch today with $5.5 million in seed funding. The round was led by TLV Partners, an Israeli venture ...

When the photoreceptors of the retina—the cells that sense light—are destroyed, the result is loss of vision. This is how the neurodegenerative eye disease retinitis pigmentosa (RP) results in ...